GDPD5 and Alzheimer disease: Supporting GDE2 dysfunction in disease, amounts of membrane RECK are increased in AD brain, and proteomic studies show a disproportionate reduction of released GPI-anchored proteins in the cerebrospinal fluid (CSF) of patients with ALS compared with controls [21, 22].